Literature DB >> 12098047

Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases.

Attila Csendes1, Patricio Burdiles, Italo Braghetto, Owen Korn, Juan Carlos Díaz, Jorge Rojas.   

Abstract

The usual surgical treatment for patients with Barrett's esophagus (BE) is a classic Nissen fundoplication or posterior gastropexy with cardial calibration. However, some surgical reports as well as our experience suggest that the rate of failure of the Nissen fundoplication or Hill's posterior gastropexy in patients with BE is significantly higher than in those with reflux esophagitis without BE, probably due in part to the persistence of duodenal reflux into the esophagus. Our aim was to determine the late subjective and objective results of an operation consisting in "acid suppression" (vagotomy-partial gastrectomy) and "duodenal diversion" (Roux-en-Y anastomosis) as a primary surgical procedure for patients with BE. Altogether, 210 patients were subjected to this technique. It consisted in a primary operation in 142 patients and revision surgery in 68. They underwent complete clinical, radiologic, endoscopic, histologic, and manometric studies. In some cases 24-hour pH studies, Bilitec studies, gastric emptying, and gastric acid secretion evaluations were performed. There were two deaths (0.95%), and postoperative morbidity was low (5.3%). The late mean follow-up (58 months) for 146 patients who completed a follow-up longer than 24 months showed Visick I and II grades in 91.1% of the cases. In 14.9% of the cases 24-hour pH monitoring showed excessive acid reflux 1 year after surgery. No dysplasia or adenocarcinoma has appeared up to now. Functional studies showed significant alleviation of lower esophageal sphincter (LES) incompetence, with abolition of duodenal reflux into the esophagus. Gastric emptying of solids was normal, and basal and peak gastric acid output remained at a low level 8 to 10 years after surgery. In patients with BE, with severe damage of the LES and esophageal peristalsis, the "suppression diversion" operation completely abolishes the reflux of injurious components of the refluxate and improves sphincter competence. This effect is permanent and avoids the appearance of dysplasia or adenocarcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 12098047     DOI: 10.1007/s00268-001-0269-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  90 in total

1.  Antrectomy with Roux-en-Y anastomosis in the treatment of peptic oesophagitis with stricture.

Authors:  C M Royston; B L Dowling; J Spencer
Journal:  Br J Surg       Date:  1975-08       Impact factor: 6.939

2.  Gastric acid secretion in patients with a symptomatic gastroesophageal reflux and patients with esophageal strictures.

Authors:  A Csendes; A Larrain; P Uribe
Journal:  Ann Surg       Date:  1974-01       Impact factor: 12.969

3.  Esophagectomy for complex benign esophageal disease.

Authors:  P F Waters; F G Pearson; T R Todd; G A Patterson; M Goldberg; R J Ginsberg; J D Cooper; J Ramirez; L Miller
Journal:  J Thorac Cardiovasc Surg       Date:  1988-03       Impact factor: 5.209

4.  Reoperation after failed antireflux surgery.

Authors:  N A Rieger; G G Jamieson; R Britten-Jones; S Tew
Journal:  Br J Surg       Date:  1994-08       Impact factor: 6.939

5.  Results of the Hill antireflux operation.

Authors:  A S Hermreck; N R Coates
Journal:  Am J Surg       Date:  1980-12       Impact factor: 2.565

6.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.

Authors:  R C Haggitt; J Tryzelaar; F H Ellis; H Colcher
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

7.  Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications.

Authors:  S E Attwood; A P Barlow; T L Norris; A Watson
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

8.  Esophageal function in patients with reflux-induced strictures and its relevance to surgical treatment.

Authors:  G Zaninotto; T R DeMeester; C G Bremner; T C Smyrk; S C Cheng
Journal:  Ann Thorac Surg       Date:  1989-03       Impact factor: 4.330

9.  Surgical management of reflux-induced oesophageal stenoses: results in 101 patients.

Authors:  W S Payne
Journal:  Br J Surg       Date:  1984-12       Impact factor: 6.939

10.  Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb.

Authors:  J R Mathias; A Fernandez; C A Sninsky; M H Clench; R H Davis
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

View more
  10 in total

1.  Classification and management of leaks after gastric bypass for patients with morbid obesity: a prospective study of 60 patients.

Authors:  Attila Csendes; Ana Maria Burgos; Italo Braghetto
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

2.  Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett's esophagus: a prospective study.

Authors:  Italo Braghetto; Owen Korn; Attila Csendes; Luis Gutiérrez; Héctor Valladares; Max Chacon
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

3.  Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity.

Authors:  Attila Csendes; Ana Maria Burgos; Gladys Smok; Patricio Burdiles; Ana Henriquez
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

4.  Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity.

Authors:  Attila Csendes; Ana Maria Burgos; Gladys Smok; Marcelo Beltran
Journal:  Obes Surg       Date:  2007-01       Impact factor: 4.129

Review 5.  Surgical treatment of gastroesophageal reflux disease.

Authors:  Christian A Gutschow; Arnulf H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2012-04-12       Impact factor: 3.445

6.  Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects.

Authors:  Italo Braghetto; Cristóbal Davanzo; Owen Korn; Attila Csendes; Héctor Valladares; Eduardo Herrera; Patricio Gonzalez; Karin Papapietro
Journal:  Obes Surg       Date:  2009-08-28       Impact factor: 4.129

Review 7.  Treatment for Barrett's oesophagus.

Authors:  Jonathan Re Rees; Pierre Lao-Sirieix; Angela Wong; Rebecca C Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Behavior of the infection by Helicobacter pylori of the gastric remnant after subtotal gastrectomy and Roux-en-Y anastomosis for benign diseases.

Authors:  Attila Csendes; Gladys Smok; Ana María Burgos
Journal:  J Gastrointest Surg       Date:  2008-07-09       Impact factor: 3.452

Review 9.  Surgical treatment of Barrett's esophagus: 1980-2003.

Authors:  Attila Csendes
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

10.  Esophageal carcinoma following bariatric procedures.

Authors:  Jeff W Allen; Matthew F Leeman; J David Richardson
Journal:  JSLS       Date:  2004 Oct-Dec       Impact factor: 2.172

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.